Search research articles
Contact Us
Filters
Showing results (261-270 of 277) with videos related to
Page
of 28
Sort By:
Neuro-Oncology
|
February 28, 2026
DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma
Kristen L Drucker, Arijit Panda, Paul A Decker, et al.
Journal of Neuropathology and Experimental Neurology
|
March 6, 2024
Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
Kliment Donev, Vanitha Sundararajan, Derek Johnson, et al.
Neuro-Oncology
|
April 14, 2026
CNS tumor type prevalence according to age group: an analysis of 21,000 cases confirmed by methylation profiling, with a focus on adolescents and young adults
Adriana Fonseca, Leeor Yefet, Omkar Singh, et al.
Neuro-Oncology Advances
|
March 30, 2026
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtype
Daniel H Lachance, Paul A Decker, Thomas M Kollmeyer, et al.
Journal of Neuropathology and Experimental Neurology
|
September 29, 2019
Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial Tumor
Melissa M Blessing, Patrick R Blackburn, Chandra Krishnan, et al.
Journal of Neuropathology and Experimental Neurology
|
June 12, 2025
FGFR1 fusions in genomically and epigenetically bona fide glioblastoma, IDH-wildtype
Riley H Lochner, Suzanne Z Powell, Kar-Ming Fung, et al.
Neuro-Oncology
|
November 5, 2025
Reflecting on Scientific Growth and Innovation as the Society for Neuro-Oncology Turns 30
Macarena I De La Fuente, Priscilla K Brastianos, Bradley Gampel, et al.
Journal of Neuropathology and Experimental Neurology
|
March 19, 2025
Expanding the spectrum of TERT promoter mutations in CNS tumors: A case series of non-canonical mutations
David J Cook, Jorge A Trejo-Lopez, Beth A Pitel, et al.
Journal of Neuropathology and Experimental Neurology
|
April 25, 2025
EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype?
David J Cook, Paul A Decker, Jayson J Hardcastle, et al.
The Journal of Molecular Diagnostics : JMD
|
February 2, 2025
Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer Biomarkers
Hussam Al-Kateb, Shannon M Knight, Gopinath Sivasankaran, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 277) with videos related to
Sort By:
Page
of 28
Neuro-Oncology
|
February 28, 2026
DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma
Kristen L Drucker, Arijit Panda, Paul A Decker, et al.
Journal of Neuropathology and Experimental Neurology
|
March 6, 2024
Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
Kliment Donev, Vanitha Sundararajan, Derek Johnson, et al.
Neuro-Oncology
|
April 14, 2026
CNS tumor type prevalence according to age group: an analysis of 21,000 cases confirmed by methylation profiling, with a focus on adolescents and young adults
Adriana Fonseca, Leeor Yefet, Omkar Singh, et al.
Neuro-Oncology Advances
|
March 30, 2026
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtype
Daniel H Lachance, Paul A Decker, Thomas M Kollmeyer, et al.
Journal of Neuropathology and Experimental Neurology
|
September 29, 2019
Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial Tumor
Melissa M Blessing, Patrick R Blackburn, Chandra Krishnan, et al.
Journal of Neuropathology and Experimental Neurology
|
June 12, 2025
FGFR1 fusions in genomically and epigenetically bona fide glioblastoma, IDH-wildtype
Riley H Lochner, Suzanne Z Powell, Kar-Ming Fung, et al.
Neuro-Oncology
|
November 5, 2025
Reflecting on Scientific Growth and Innovation as the Society for Neuro-Oncology Turns 30
Macarena I De La Fuente, Priscilla K Brastianos, Bradley Gampel, et al.
Journal of Neuropathology and Experimental Neurology
|
March 19, 2025
Expanding the spectrum of TERT promoter mutations in CNS tumors: A case series of non-canonical mutations
David J Cook, Jorge A Trejo-Lopez, Beth A Pitel, et al.
Journal of Neuropathology and Experimental Neurology
|
April 25, 2025
EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype?
David J Cook, Paul A Decker, Jayson J Hardcastle, et al.
The Journal of Molecular Diagnostics : JMD
|
February 2, 2025
Clinical Validation of the TruSight Oncology 500 Assay for the Detection and Reporting of Pan-Cancer Biomarkers
Hussam Al-Kateb, Shannon M Knight, Gopinath Sivasankaran, et al.
Page
of 28